Back
Warby Parker Vs. Perspective Therapeutics Industry Stock Comparison
Buy
64
WRBY
Warby Parker
Last Price:
23.09
Seasonality Move:
-5.17%
Sell
30
CATX
Perspective Therapeutics
Last Price:
3.49
Seasonality Move:
34.33%
Buy
64
Warby Parker (WRBY)
is a Buy
Is Warby Parker a Buy, Sell or Hold?
- The current Warby Parker [WRBY] share price is $23.27. The Score for WRBY is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- WRBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.00. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
WRBY Stock Price Chart
What is Warby Parker's stock price today?
-
The Warby Parker share price today is $23.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WRBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.00
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
WRBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.73 | Buy |
| Relative Strength Index (14 RSI): | 85.6 | Buy |
| Chaikin Money Flow: | 1397237 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.02 - 21.52) | Buy |
| Bollinger Bands (100): | (13.89 - 18.47) | Buy |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.83 | Sell |
| Relative Strength Index (14 RSI): | 9.64 | Sell |
| Chaikin Money Flow: | -11653674 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.08 - 12.98) | Sell |
| Bollinger Bands (100): | (10.5 - 14.68) | Sell |
WRBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.2 | Buy |
| 20-day SMA: | 19.73 | Buy |
| 50-day SMA: | 17.37 | Buy |
| 200-day SMA: | 15.19 | Buy |
| 8-day EMA: | 22.16 | Buy |
| 20-day EMA: | 20.34 | Buy |
| 50-day EMA: | 18.18 | Buy |
| 200-day EMA: | 15.69 | Buy |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.54 | Sell |
| 20-day SMA: | 10.1 | Sell |
| 50-day SMA: | 11.82 | Sell |
| 200-day SMA: | 12.75 | Sell |
| 8-day EMA: | 7.04 | Sell |
| 20-day EMA: | 9.29 | Sell |
| 50-day EMA: | 11.19 | Sell |
| 200-day EMA: | 11.43 | Sell |
Warby Parker Earnings Growth & WRBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.08 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.
Warby Parker Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||